Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme

Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings

(2014) Daniel E. Jonas et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study

(2014) Wim van den Brink et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies

(2013) W. van den Brink et al.   ALCOHOL AND ALCOHOLISM

Effect of Nalmefene 20 and 80 mg on the Corrected QT Interval and T-Wave Morphology

(2013) Jørgen Matz et al.   CLINICAL DRUG INVESTIGATION

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence

(2013) Antoni Gual et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence

(2013) Raye Z. Litten et al.   Journal of Addiction Medicine

The role of the opioid system in alcohol dependence

(2013) David J Nutt   JOURNAL OF PSYCHOPHARMACOLOGY

Addiction is a Reward Deficit and Stress Surfeit Disorder

(2013) George F. Koob   Frontiers in Psychiatry

Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene

(2012) Karl Mann et al.   BIOLOGICAL PSYCHIATRY

The size and burden of mental disorders and other disorders of the brain in Europe 2010

(2011) H.U. Wittchen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study

(2011) Gihyun Yoon et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Initial Preference for Drinking Goal in the Treatment of Alcohol Problems: I. Baseline Differences Between Abstinence and Non-Abstinence Groups

(2010) N. Heather et al.   ALCOHOL AND ALCOHOLISM

Efficacy and Tolerability of Naltrexone in the Management of Alcohol Dependence

(2010) James C. Garbutt   CURRENT PHARMACEUTICAL DESIGN

The core characteristics and nursing care activities in psychiatric intensive care units in Sweden

(2008) Martin Salzmann-Erikson et al.   International Journal of Mental Health Nursing

Acamprosate: Safety and Tolerability in the Treatment of Alcohol Dependence

(2008) Richard N. Rosenthal et al.   Journal of Addiction Medicine